The FRAP technology: An innovative glue for fracture treatment
|Coordinator||REPAIR TECHNOLOGIES SWEDEN AB|
|Funding from Vinnova||SEK 856 300|
|Project duration||December 2013 - October 2014|
Purpose and goal
After the implementation of the very positive in vitro cell studies from the innovative FRAP - technology, the project aims to transfer the results from laboratory scale to an exploratory first step toward clinical application and further product development in the first fracture treatment. This will form the basis for the long-term goal of Repair Technologies Sweden AB to be developed into an innovative Swedish medical technology company in materials engineering located in Sweden to potentially replace existing metals with the FRAP - technology in health care on the global market.
Results and expected effects
The activities of the project has mainly resulted in the presentation of the innovative FRAP - technology for scientists, research engineers and surgeons as a new and effective fracture treatment. The expected effect is that the FRAP - technology laid the foundation for a close interdisciplinary collaboration on innovative materials technologies for clinical application and the potential replacement of metals in health care through the development of new products for clinical application in other disease states, and which will lead to more effective treatment results.
Approach and implementation
The project has been divided into four different work packages with the headlines Project Management and Clinical Development (WP 1), Business Development (WP 2), Additional design and development of FRAP - technology product (WP 3), and Training and testing of the FRAP technology prototype (WP 4). Each work package has identified the essential activities and equipment and how the results from these items are presented. In addition, each work package defined deadlines for each of the activities to be delivered and type of strategic decision points that formed the basis of the results.